D.A. Davidson & Co. Shockwave Medical, Inc. Transaction History

D.A. Davidson & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$204.38 - $296.82 $47,416 - $68,862	-232 Reduced 11.46%	1,792 $368,000
Q3 2022 Nov 07, 2022	BUY	$195.21 - $310.53 $126,691 - $201,533	649 Added 47.2%	2,024 $563,000
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $38,388 - $62,208	-300 Reduced 17.91%	1,375 $285,000
Q3 2021 Nov 15, 2021	SELL	$163.99 - $235.57 $8,199 - $11,778	-50 Reduced 2.9%	1,675 $345,000
Q2 2021 Aug 10, 2021	SELL	$131.45 - $201.49 $31,547 - $48,357	-240 Reduced 12.21%	1,725 $327,000
Q1 2021 May 07, 2021	SELL	$92.73 - $142.05 $18,546 - $28,410	-200 Reduced 9.24%	1,965 $256,000
Q4 2020 Feb 10, 2021	BUY	$67.44 - $103.72 $146,007 - $224,553	2,165 New	2,165 $225,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.